Drug Profile
Research programme: LPAAT-beta inhibitors - Cell Therapeutics
Alternative Names: CT-32228; LPAAT-B inhibitors research programme - Cell Therapeutics; LPAAT-beta inhibitors research programme - Cell TherapeuticsLatest Information Update: 01 Sep 2005
Price :
$50
*
At a glance
- Originator Cell Therapeutics
- Class Small molecules
- Mechanism of Action Lysophosphatidic acid acyltransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 01 Sep 2005 Discontinued - Preclinical for Cancer in USA (unspecified route)
- 01 Jul 2005 A preclinical study has been added to the cancer pharmacodynamics section
- 16 Apr 2004 This programme is still in active development - (95th Annual Meeting of the American Association for Cancer Research [AACR-2004])